cilostazol has been researched along with aripiprazole in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Choi, BT; Hong, KW; Kim, HN; Kim, YR; Shin, HK | 1 |
| Heo, HJ; Hong, KW; Kim, CD; Kim, HY; Lee, WS; Lee, YS; Park, SY; Shin, HK | 1 |
1 review(s) available for cilostazol and aripiprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for cilostazol and aripiprazole
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke.
Topics: Animals; Antidepressive Agents; Aripiprazole; Atrophy; Behavior, Animal; Brain; Cell Differentiation; Cell Proliferation; Cilostazol; CREB-Binding Protein; Depression; Disease Models, Animal; Drug Synergism; Male; Mice; Neural Stem Cells; Phenotype; Phosphorylation; Stress, Psychological; Stroke; Tetrazoles | 2017 |
Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model.
Topics: Animals; Aripiprazole; Brain; Brain Ischemia; Carotid Stenosis; Cilostazol; Cognition; Cognitive Dysfunction; Dementia, Vascular; Disease Models, Animal; Drug Therapy, Combination; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Spatial Learning | 2019 |